CRL Annual Revenue
$4.13 B
+$153.35 M+3.86%
30 December 2023
Summary:
As of January 20, 2025, CRL annual revenue is $4.13 billion, with the most recent change of +$153.35 million (+3.86%) on December 30, 2023. During the last 3 years, it has risen by +$1.21 billion (+41.23%). CRL annual revenue is now at all-time high.CRL Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRL Quarterly Revenue
$1.01 B
-$16.35 M-1.59%
28 September 2024
Summary:
As of January 20, 2025, CRL quarterly revenue is $1.01 billion, with the most recent change of -$16.35 million (-1.59%) on September 28, 2024. Over the past year, it has dropped by -$3.71 million (-0.37%). CRL quarterly revenue is now -8.19% below its all-time high of $1.10 billion, reached on December 31, 2022.CRL Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRL TTM Revenue
$4.06 B
-$16.86 M-0.41%
28 September 2024
Summary:
As of January 20, 2025, CRL TTM revenue is $4.06 billion, with the most recent change of -$16.86 million (-0.41%) on September 28, 2024. Over the past year, it has dropped by -$68.49 million (-1.66%). CRL TTM revenue is now -3.67% below its all-time high of $4.22 billion, reached on September 30, 2023.CRL TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRL Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +3.9% | -0.4% | -1.7% |
| 3 y3 years | +41.2% | -0.4% | -1.7% |
| 5 y5 years | +82.2% | -0.4% | -1.7% |
CRL Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +16.6% | -8.2% | +11.6% | -3.7% | +14.7% |
| 5 y | 5-year | at high | +57.5% | -8.2% | +47.9% | -3.7% | +54.9% |
| alltime | all time | at high | +2036.3% | -8.2% | +1292.7% | -3.7% | +5501.1% |
Charles River Laboratories International Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.01 B(-1.6%) | $4.06 B(-0.4%) |
| June 2024 | - | $1.03 B(+1.4%) | $4.08 B(-0.8%) |
| Mar 2024 | - | $1.01 B(-0.2%) | $4.11 B(-0.4%) |
| Dec 2023 | $4.13 B(+3.9%) | $1.01 B(-1.3%) | $4.13 B(-2.0%) |
| Sept 2023 | - | $1.03 B(-3.1%) | $4.22 B(+0.9%) |
| June 2023 | - | $1.06 B(+3.0%) | $4.18 B(+2.1%) |
| Mar 2023 | - | $1.03 B(-6.4%) | $4.09 B(+2.9%) |
| Dec 2022 | $3.98 B(+12.3%) | $1.10 B(+11.2%) | $3.98 B(+5.2%) |
| Sept 2022 | - | $989.16 M(+1.6%) | $3.78 B(+2.5%) |
| June 2022 | - | $973.13 M(+6.5%) | $3.69 B(+1.6%) |
| Mar 2022 | - | $913.93 M(+1.0%) | $3.63 B(+2.5%) |
| Dec 2021 | $3.54 B(+21.1%) | $905.05 M(+1.0%) | $3.54 B(+3.3%) |
| Sept 2021 | - | $895.94 M(-2.0%) | $3.43 B(+4.7%) |
| June 2021 | - | $914.61 M(+10.9%) | $3.27 B(+7.6%) |
| Mar 2021 | - | $824.57 M(+4.2%) | $3.04 B(+4.0%) |
| Dec 2020 | $2.92 B(+11.5%) | $790.99 M(+6.4%) | $2.92 B(+3.5%) |
| Sept 2020 | - | $743.30 M(+8.9%) | $2.82 B(+2.7%) |
| June 2020 | - | $682.58 M(-3.5%) | $2.75 B(+0.9%) |
| Mar 2020 | - | $707.06 M(+2.3%) | $2.72 B(+3.9%) |
| Dec 2019 | $2.62 B(+15.7%) | $691.14 M(+3.5%) | $2.62 B(+3.5%) |
| Sept 2019 | - | $667.95 M(+1.6%) | $2.53 B(+3.4%) |
| June 2019 | - | $657.57 M(+8.8%) | $2.45 B(+3.0%) |
| Mar 2019 | - | $604.57 M(+0.5%) | $2.38 B(+4.9%) |
| Dec 2018 | $2.27 B(+22.0%) | $601.53 M(+2.8%) | $2.27 B(+5.7%) |
| Sept 2018 | - | $585.29 M(-0.0%) | $2.14 B(+6.0%) |
| June 2018 | - | $585.30 M(+18.5%) | $2.02 B(+6.1%) |
| Mar 2018 | - | $493.97 M(+3.2%) | $1.91 B(+2.6%) |
| Dec 2017 | $1.86 B(+10.5%) | $478.48 M(+3.1%) | $1.86 B(+0.6%) |
| Sept 2017 | - | $464.23 M(-1.0%) | $1.85 B(+2.1%) |
| June 2017 | - | $469.13 M(+5.2%) | $1.81 B(+2.0%) |
| Mar 2017 | - | $445.76 M(-4.5%) | $1.77 B(+5.4%) |
| Dec 2016 | $1.68 B(+23.3%) | $466.79 M(+9.6%) | $1.68 B(+7.2%) |
| Sept 2016 | - | $425.72 M(-1.9%) | $1.57 B(+5.1%) |
| June 2016 | - | $434.06 M(+22.3%) | $1.49 B(+6.8%) |
| Mar 2016 | - | $354.87 M(+0.3%) | $1.40 B(+2.5%) |
| Dec 2015 | $1.36 B(+5.1%) | $353.85 M(+1.3%) | $1.36 B(+1.8%) |
| Sept 2015 | - | $349.46 M(+2.9%) | $1.34 B(+1.7%) |
| June 2015 | - | $339.57 M(+6.0%) | $1.32 B(-0.1%) |
| Mar 2015 | - | $320.41 M(-2.8%) | $1.32 B(+1.6%) |
| Dec 2014 | $1.30 B(+11.3%) | $329.55 M(+0.6%) | $1.30 B(+3.2%) |
| Sept 2014 | - | $327.57 M(-4.0%) | $1.26 B(+2.9%) |
| June 2014 | - | $341.18 M(+14.0%) | $1.22 B(+4.1%) |
| Mar 2014 | - | $299.37 M(+3.5%) | $1.17 B(+0.7%) |
| Dec 2013 | $1.17 B(+3.2%) | $289.23 M(-1.0%) | $1.17 B(+0.8%) |
| Sept 2013 | - | $292.13 M(-0.3%) | $1.16 B(+1.2%) |
| June 2013 | - | $292.93 M(+0.6%) | $1.14 B(+0.7%) |
| Mar 2013 | - | $291.24 M(+4.0%) | $1.13 B(+0.5%) |
| Dec 2012 | $1.13 B | $280.14 M(+0.5%) | $1.13 B(-0.9%) |
| Sept 2012 | - | $278.69 M(-2.1%) | $1.14 B(+0.1%) |
| June 2012 | - | $284.72 M(-0.4%) | $1.14 B(-0.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | - | $285.98 M(-1.7%) | $1.14 B(+0.0%) |
| Dec 2011 | $1.14 B(+0.8%) | $290.96 M(+4.8%) | $1.14 B(+0.8%) |
| Sept 2011 | - | $277.58 M(-3.7%) | $1.13 B(+0.6%) |
| June 2011 | - | $288.26 M(+0.8%) | $1.13 B(-0.0%) |
| Mar 2011 | - | $285.84 M(+1.5%) | $1.13 B(-0.6%) |
| Dec 2010 | $1.13 B(-3.3%) | $281.65 M(+4.0%) | $1.13 B(+1.5%) |
| Sept 2010 | - | $270.88 M(-6.1%) | $1.12 B(-2.3%) |
| June 2010 | - | $288.59 M(-1.3%) | $1.14 B(-1.7%) |
| Mar 2010 | - | $292.29 M(+10.5%) | $1.16 B(-0.8%) |
| Dec 2009 | $1.17 B(-12.8%) | $264.47 M(-11.1%) | $1.17 B(-3.9%) |
| Sept 2009 | - | $297.49 M(-3.5%) | $1.22 B(-3.5%) |
| June 2009 | - | $308.16 M(+2.2%) | $1.26 B(-3.4%) |
| Mar 2009 | - | $301.53 M(-3.2%) | $1.31 B(-2.7%) |
| Dec 2008 | $1.34 B(+9.2%) | $311.45 M(-9.0%) | $1.34 B(-0.5%) |
| Sept 2008 | - | $342.23 M(-2.8%) | $1.35 B(+2.1%) |
| June 2008 | - | $352.13 M(+4.3%) | $1.32 B(+3.5%) |
| Mar 2008 | - | $337.69 M(+6.2%) | $1.28 B(+3.8%) |
| Dec 2007 | $1.23 B(+16.3%) | $318.03 M(+1.3%) | $1.23 B(+3.9%) |
| Sept 2007 | - | $313.96 M(+2.1%) | $1.18 B(+4.3%) |
| June 2007 | - | $307.44 M(+5.6%) | $1.14 B(+3.6%) |
| Mar 2007 | - | $291.20 M(+7.2%) | $1.10 B(+3.5%) |
| Dec 2006 | $1.06 B(+6.5%) | $271.73 M(+2.7%) | $1.06 B(+11.5%) |
| Sept 2006 | - | $264.66 M(-1.2%) | $948.91 M(-1.0%) |
| June 2006 | - | $267.86 M(+5.4%) | $958.19 M(+1.8%) |
| Mar 2006 | - | $254.14 M(+56.6%) | $941.22 M(-2.0%) |
| Dec 2005 | $993.33 M(+37.2%) | $162.25 M(-40.8%) | $960.80 M(-3.3%) |
| Sept 2005 | - | $273.94 M(+9.2%) | $993.91 M(+10.9%) |
| June 2005 | - | $250.89 M(-8.3%) | $896.00 M(+8.6%) |
| Mar 2005 | - | $273.72 M(+40.1%) | $825.31 M(+14.0%) |
| Dec 2004 | $724.22 M(+18.0%) | $195.37 M(+11.0%) | $724.22 M(+5.7%) |
| Sept 2004 | - | $176.03 M(-2.3%) | $684.90 M(+3.8%) |
| June 2004 | - | $180.19 M(+4.4%) | $660.06 M(+4.1%) |
| Mar 2004 | - | $172.64 M(+10.6%) | $634.24 M(+3.3%) |
| Dec 2003 | $613.72 M(+10.7%) | $156.04 M(+3.2%) | $613.72 M(+2.2%) |
| Sept 2003 | - | $151.19 M(-2.1%) | $600.63 M(+1.7%) |
| June 2003 | - | $154.36 M(+1.5%) | $590.80 M(+3.1%) |
| Mar 2003 | - | $152.13 M(+6.4%) | $572.93 M(+3.3%) |
| Dec 2002 | $554.63 M(+19.1%) | $142.94 M(+1.1%) | $554.63 M(+3.1%) |
| Sept 2002 | - | $141.36 M(+3.6%) | $537.78 M(+3.4%) |
| June 2002 | - | $136.50 M(+2.0%) | $520.10 M(+3.9%) |
| Mar 2002 | - | $133.82 M(+6.1%) | $500.42 M(+7.5%) |
| Dec 2001 | $465.63 M(+51.9%) | $126.09 M(+1.9%) | $465.63 M(+10.7%) |
| Sept 2001 | - | $123.69 M(+5.9%) | $420.59 M(+12.9%) |
| June 2001 | - | $116.82 M(+18.0%) | $372.50 M(+11.8%) |
| Mar 2001 | - | $99.03 M(+22.2%) | $333.11 M(+8.7%) |
| Dec 2000 | $306.58 M(+32.5%) | $81.06 M(+7.2%) | $306.58 M(+35.9%) |
| Sept 2000 | - | $75.59 M(-2.4%) | $225.53 M(+50.4%) |
| June 2000 | - | $77.43 M(+6.8%) | $149.93 M(+106.8%) |
| Mar 2000 | - | $72.50 M | $72.50 M |
| Dec 1999 | $231.41 M(+19.7%) | - | - |
| Dec 1998 | $193.30 M | - | - |
FAQ
- What is Charles River Laboratories International annual revenue?
- What is the all time high annual revenue for Charles River Laboratories International?
- What is Charles River Laboratories International annual revenue year-on-year change?
- What is Charles River Laboratories International quarterly revenue?
- What is the all time high quarterly revenue for Charles River Laboratories International?
- What is Charles River Laboratories International quarterly revenue year-on-year change?
- What is Charles River Laboratories International TTM revenue?
- What is the all time high TTM revenue for Charles River Laboratories International?
- What is Charles River Laboratories International TTM revenue year-on-year change?
What is Charles River Laboratories International annual revenue?
The current annual revenue of CRL is $4.13 B
What is the all time high annual revenue for Charles River Laboratories International?
Charles River Laboratories International all-time high annual revenue is $4.13 B
What is Charles River Laboratories International annual revenue year-on-year change?
Over the past year, CRL annual revenue has changed by +$153.35 M (+3.86%)
What is Charles River Laboratories International quarterly revenue?
The current quarterly revenue of CRL is $1.01 B
What is the all time high quarterly revenue for Charles River Laboratories International?
Charles River Laboratories International all-time high quarterly revenue is $1.10 B
What is Charles River Laboratories International quarterly revenue year-on-year change?
Over the past year, CRL quarterly revenue has changed by -$3.71 M (-0.37%)
What is Charles River Laboratories International TTM revenue?
The current TTM revenue of CRL is $4.06 B
What is the all time high TTM revenue for Charles River Laboratories International?
Charles River Laboratories International all-time high TTM revenue is $4.22 B
What is Charles River Laboratories International TTM revenue year-on-year change?
Over the past year, CRL TTM revenue has changed by -$68.49 M (-1.66%)